San Diego, CA, United States of America

Malcolm Schinstine

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Malcolm Schinstine. Retrieved from https://idiyas.com/inventor/malcolm-schinstine-t5r7s43k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Malcolm Schinstine

Introduction

Malcolm Schinstine is a prominent inventor based in San Diego, California. He has made significant contributions to the field of genetic engineering, particularly in the treatment of central nervous system disorders. With a total of 2 patents, his work focuses on innovative methods for grafting genetically modified cells.

Latest Patents

Schinstine's latest patents include a groundbreaking method of grafting genetically modified cells to treat defects and diseases. This method involves genetically modifying donor cells through gene transfer for grafting into the central nervous system. The modified donor cells are designed to produce functional molecules that enhance the recovery or improve the function of cells within the CNS. The patents detail various methods and vectors for executing gene transfer and grafting, showcasing Schinstine's commitment to advancing medical science.

Career Highlights

Malcolm Schinstine is affiliated with the University of California, where he continues to push the boundaries of research in genetic modification. His work has garnered attention for its potential to revolutionize treatments for neurological conditions.

Collaborations

Throughout his career, Schinstine has collaborated with notable colleagues, including Fred Harrison Gage and Theodore Friedmann. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Malcolm Schinstine's contributions to genetic engineering and his innovative patents reflect his dedication to improving medical treatments for central nervous system disorders. His work continues to inspire advancements in the field and holds promise for future breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…